course career question whether women take antidepressants pregnant recurring question point counterpoint seems depend whether psychiatrist treating women severe forms depression lot studies seem driven fact registry somewhere pregnant women exposure various medications studies like make headlines simplistically interpreted much different perspective psychiatrist talking woman severe postpartum depression want experience also case acute care psychiatrists assessed many women significant change mood mental state pregnancy never recovered became chronically mentally ill point sustained expected comorbidity first times i encountered situation difficult accept nobody teaches medical school residency training seemed like well kept secret since i seen many women developed chronic mental illness started severe mood change immediately pregnancy recent question arose result study reference analysis quebec pregnancy cohort authors additional references medline full text available current study conclusion authors ssri snri tca type antidepressants associated significant increase congential malformations specifically cardiac musculoskeletal craniofacial digestive respiratory defects authors detailed flow diagram details patient selection original cohort pregnancies flow diagram good illustration original cohort narrowed pregnancies either first trimester exposure antidepressants exposure subgroups antidepressant exposure include ssris snris tcas numbers percentages major malformations group exposure ssri snri tca ten year course study prevalence antidepressant use doubled women per pregnancies quick arithmetic numbers find antidepressant exposed pregnancies resulted major congenital malformations using baseline rate unexposed pregnancies calculate expected number major malformations results difference major malformations exposed group pregnancies authors consider major malformations used definitions major congenital malformations according conventions two databases provided icd icd diagnostic codes named diagnoses far i could tell concern literature congenital malformations varies bit terms rate birth defects whether considered major expressed nejm editorial greene commenting two papers subject major congenital malformations associated ssris edition notes survey aggregate data available positive negative equivocal makes clear neither ssris group individual ssris major teratogens order thalidomide isotretinoin goes elaborate low risk ssris zero clear cut opinion contrast written since suggesting risk high enough women exposed ssris one strengths study used depressed anxious mothers reference group attempt remove confounders due conditions variety diagnostic codes determined including icd codes episodic mood disorders icd codes neurotic disorders icd codes depressed anxious cognitive disorders icd codes adjustment disorders icd codes depression otherwise specified data indications antidepressant use available authors sought limit indication bias comparing women selected diagnoses depression women selected diagnoses anxiety depression treated antidepressants one year pregnancy several exclusion criteria exposure one antidepressant multiple births applied total psychiatric visits viewed proxy measure severity rather confirmation diagnosis primary statistic used paper odds ratio adjusted odds ratio aor i skeptical applications past also theoretical concerns discussed reference authors present excellent argument widely used epidemiological studies characterizes population variations risk weakness low accuracy classifying marker tends overestimate relative risk sample size low number papers also point large numbers comparisons done like calculating aor large number antidepressants likely findings explained chance case calculations antidepressant overall major congenital malformations individual body systems conclude exposure citalopram aor ci first trimester increases risk major malformations trend antidepressants ads ads seemed result system specific malformations another methodological problem occur affect comparisons control group unexpectedly large number malformations happened research studies much larger study problem provided nice consortium uk page document subject supplement forest plots alone document additional pages long authors document carefully selected studies prenatal exposure psychiatric medications compiled fairly large studies also showed actual numbers lesions exposed unexposed groups rates absolute differences addition nice methodology exhaustive included large number patients across major drug classes antidepressants antipsychotics anticonvulsants lithium benzodiazepines stimulants antidepressants studies listed sample sizes ranging according authors statistically increased risk major congenital malformations ssris even though absolute risk difference per possible system specific risks paroxetine fluoxetine range absolute risk difference per guideline translated series prescribing principles could applied prescribing antidepressants pregnancy p principles amount detailed informed consent discussion potential risk pregnancy breastfeeding document also contains observation women stop taking medication find pregnant often happens without consultation attending meetings psychiatrists presenters focused maternal health provides much different perspective pregnancy databases focused congenital malformations past couple years i attend three conferences two occurred university wisconsin annual updates three conferences maternal burden anxiety depression context generally presented first katherine wisner presented madison last year arguments based fact psychiatric disorders common chronic conditions women childbearing age rate treatment low non pregnant women women pregnant past year pointed medication free disease free pregnancies myth pregnant women get sick sick women get pregnant pregnant women new episode depression women episode postpartum depression dr wisner one several authors referenced cohen work recurrence risk depression women discontinued antidepressants around time conception versus versus click enlarge graphic jama feb permission presentation zachary stowe used cohen survival curve illustrate recurrent depression antidepressant discontinuation pregnancy also showed survival curves treated versus untreated bipolar disorder viguera showing untreated pregnant bipolar patient relapse pregnancy ot weeks post partum compared treated bipolar patients also two excellent slides acute maternal neonatal consequences relapse mood disorder documenting numerous neonatal complications maternal complications including suicide michelle wiersgalla expanded postpartum disorders include anxiety psychosis pointed suicide accounts post partum deaths suicide second leading cause death post partum women sources classified leading cause maternal death infanticide occurs rate associated post partum psychosis presenters would seem made strong case treating mood anxiety disorders pregnancy course sterile research statistics nothing like stress clinical practice patient suddenly destabilized becomes unpredictable family treating physician also stress unplanned pregnancy woman treated psychiatric disorder speaks one dr stowe main point treat women childbearing age practice potentially pregnant documenting method contraception advice adn planning pregnancy given medication taking seems me recurring problem antidepressant safety pregnancy driven large body research widely discrepant low frequency findings generally talking rates single low double digits thousand i think conclusions research probably affected find people interested proving antidepressants harmful one hand likely write perspective minimize completely ignore severity associated women mental health problems fact clearly treated antidepressants also never mention potentially severe outcomes associated untreated postpartum depression observed acute care settings hand research written perspective treating women mental health problems unexpectedly show less harm clinicians especially psychiatrists front lines often left advising women unexpected pregnancies antidepressant treatment stuck middle reasonable informed consent discussion women childbearing age begins treating women category though potentially pregnancy time includes history pregnancy associated changes mood anxiety also includes discussion going risk state fetus pregnant taking medications pregnancy taking medication includes plans pregnancy documenting method birth control high risk drugs screening pregnancy done concern absolute minimization risk pregnancy screening done repeated necessary case planned pregnancies window months prior conception allows scheduled taper discontinuation antidepressant medication psychiatric evaluation valuable determine risk relapse situations many patients started taking antidepressants acute situations stressor longer applies many patients taking antidepressants anxiety disorders never received psychotherapies anxiety practical measures exhausted decision comes whether unplanned pregnancy exposure situation discontinuation antidepressants would potentially problematic cases i involved women also seeing high risk obstetric specialists pregnancies closely monitored far actual drugs go i think paroxetine prescribed i basing anything pregnancy congenital malformation literature i basing experience psychiatry fact first years release i determined problematic drug terms drug interactions discontinuation symptoms prescribe problematic drug plenty equivalent drugs i understand anyone prescribes paroxetine days said look data analyses pregnancy registries difference complication rates drugs narrow small difference changing another drug lower odds ratio congenital malformations probably makes little sense mean nobody want change patient preference case requires thorough neutral discussion george dawson md dfapa references rard zhao jp sheehy antidepressant use pregnancy risk major congenital malformations cohort depressed pregnant women updated analysis quebec pregnancy cohort bmj open jan doi bmjopen pubmed pmid greene mf teratogenicity ssris serious concern much ado little engl med jun pubmed pmid alwan reefhuis rasmussen sa et al use selective serotonin reuptake inhibitors pregnancy risk birth defects engl med louik lin ae werler mm hernandez diaz mitchell aa first trimester use selective serotonin reuptake inhibitors risk birth defects engl med andrade understanding relative risk odds ratio related terms simple get clin psychiatry jul doi jcp f pubmed pmid pepe ms janes longton leisenring newcomb p limitations odds ratio gauging performance diagnostic prognostic screening marker epidemiol https doi org aje kwh davies ht crombie ik tavakoli odds ratios mislead bmj mar review pubmed pmid deeks odds ratios mislead odds ratios used case control studies logistic regression analyses bmj oct author reply pubmed pmid bracken mb sinclair jc odds ratios mislead avoidable systematic error estimating treatment effects must tolerated bmj oct author reply pubmed pmid zachary stowe md treatment mood disorders pregnancy lactation presented nd annual update advances psychiatry october madison wisconsin katherine wisner md ms treating depression pregnancy asking right questions presented th annual update advances psychiatry october madison wisconsin michelle wiersgalla md postpartum mood anxiety disorders presented minnesota psychiatric society october oates suicide leading cause maternal death br psychiatry oct pubmed pmid knight nair tuffnell kenyon shakespeare brocklehurst p kurinczuk jj eds behalf mbrrace uk saving lives improving mothers care surveillance maternal deaths uk lessons learned inform maternity care uk ireland confidential enquiries maternal deaths morbidity oxford national perinatal epidemiology unit university oxford maternal suicides reclassified world health organisation direct cause maternal death rate maternal death suicide remains unchanged since maternal suicides leading cause direct maternal deaths occurring within year end pregnancy p cohen ls altshuler harlow bl nonacs r newport dj viguera ac suri r burt vk hendrick v reminick loughead vitonis af stowe zn relapse major depression pregnancy women maintain discontinue antidepressant treatment jama feb erratum jama jul pubmed pmid viguera ac whitfield baldessarini rj newport dj stowe z reminick zurick cohen ls risk recurrence women bipolar disorder pregnancy prospective study mood stabilizer discontinuation psychiatry dec quiz pubmed pmid national collaborating centre mental health antenatal postnatal mental health clinical management service guidance updated edition national clinical guideline number specific guidelines treating depression pregnancy psychiatrists starts page continues full gamut treatment interventions context clinical history evaluation patient preferences informed consent presented antidepressants congenital malformation antidepressants congenital malformation antidepressants pregnancy attribution figure post reference figure entitled figure kaplan meier curves illustrating time relapse medication categories medication reintroduction categories permission american medical association order number thank ama supplementary i tried get permission post survival curves references apa i year member wanted charge me repost single year old graphic i seen used presentations supplementary graphics top actual fliers two conferences mentioned two years residency training i affiliation university wisconsin department psychiatry